`
`Paper No. _____
`Date Filed: November 3, 2017
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`SAWAI USA, INC. and SAWAI PHARMACEUTICAL CO., LTD.
`Petitioners,
`
`v.
`
`ASTELLAS PHARMA INC.,
`Patent Owner.
`________________
`
`Case IPR2018-00079
`Patent 6,346,532
`________________
`
`ASTELLAS PHARMA INC.,
`MANDATORY NOTICES – 37 C.F.R. § 42.8
`
`
`
`Pursuant to 37 C.F.R. § 42.8, Astellas Pharma Inc., the patent owner,
`
`submits the following Mandatory Notices.
`
`Real Party-In-Interest:
`
`The real party-in-interest is Astellas Pharma Inc., a Japanese corporation
`
`with a principal place of business at 2-5-1 Nihonbashi-Honcho, Chuo-Ku, Tokyo
`
`103-8411, Japan. Astellas Pharma Inc. is the owner of U.S. Patent No. 6,346,532
`
`(’532 Patent). Assignments were recorded with the U.S. Patent and Trademark
`
`Office for the ’532 Patent on April 7, 2000, at Reel No. 010808, Frame No. 0313,
`
`and on November 16, 2005, at Reel No. 016784, Frame No. 0361.
`
`Related Matters:
`
`Astellas is aware of the following related litigation matters:
`
`(a) Astellas Pharma Inc., et al. v. Sawai USA, Inc., et al., No. 16-cv-954-
`
`JFB-CJB (D. Del. 2016); and
`
`(b) Astellas Pharma Inc., et al. v. Actavis Elizabeth LLC, et al., No. 16-cv-
`
`905-JFB-CJB (D. Del. 2016);
`
`Both related litigation matters are consolidated under Astellas Pharma Inc.,
`
`et al. v. Actavis Elizabeth LLC, et al., No. 16-cv-905-JFB-CJB (D. Del. 2016).
`
`Lead and Back-Up Counsel:
`
`Astellas designates the following lead and back-up counsel:
`
`- 2 -
`
`
`
`LEAD COUNSEL
`
`BACK-UP COUNSEL
`
`Robert L. Baechtold (Reg. No. 20,860)
`
`Scott K. Reed (Reg. No. 32,433)
`
`Fitzpatrick, Cella, Harper & Scinto
`
`Fitzpatrick, Cella, Harper & Scinto
`
`1290 Avenue of the Americas
`
`1290 Avenue of the Americas
`
`New York, NY 10104
`
`New York, NY 10104
`
`Tel: (212) 218-2100
`
`Fax: (212) 218-2200
`
`RBaechtold@fchs.com
`
`Tel: (212) 218-2100
`
`Fax: (212) 218-2200
`
`SReed@fchs.com
`
`Simon D. Roberts (Reg. No. 47,342)
`
`Fitzpatrick, Cella, Harper & Scinto
`
`1290 Avenue of the Americas
`
`New York, NY 10104
`
`Tel: (212) 218-2100
`
`Fax: (212) 218-2200
`
`SRoberts@fchs.com
`
`The designated counsel are already counsel of record for the ’532 Patent.
`
`Service Information:
`
`Astellas consents to electronic service at the above email addresses for lead
`
`and backup counsel and the following email address:
`
`Astellas532IPR@fchs.com
`- 3 -
`
`
`
`Any questions concerning this paper may be directed to lead counsel listed
`
`below.
`
`Respectfully submitted,
`
`/Robert L. Baechtold/
`Robert L. Baechtold
`Lead Counsel for Patent Owner
`Registration No. 20,860
`Tel: (212) 218-2100
`
`Fitzpatrick, Cella, Harper & Scinto
`1290 Avenue of the Americas
`New York, NY 10104
`Tel: (212) 218-2100
`Fax: (212) 218-2200
`
`- 4 -
`
`
`
`CERTIFICATE OF SERVICE
`
`I certify that a copy of the Patent Owner’s Mandatory Notices was served on
`
`Petitioners via email on this date at the following email addresses:
`
`brian.sodikoff@kattenlaw.com
`martin.masar@kattenlaw.com
`
`Dated: November 3, 2017
`
`Respectfully submitted,
`
`/Robert L. Baechtold/
`Robert L. Baechtold
`Lead Counsel for Patent Owner
`Registration No. 20860
`Tel: (212) 218-2100
`
`FCHS_WS 13840265v4.doc
`
`- 5 -
`
`